Replimune (REPL) Return on Assets [ROA] (2018 - 2026)
Replimune (REPL) reported Return on Assets [ROA] of -86.17% for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 14.05 percentage points from -72.13% a year earlier but up 14.73 percentage points from the prior quarter.
Powered by 
Analysis
Replimune (REPL) Return on Assets [ROA] (2018 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Replimune posted Return on Assets [ROA] of -71.17%, down 23.66 percentage points from FY2025.
- Return on Assets [ROA] has declined for five consecutive fiscal years, with a five-year change of -50.62 percentage points (FY2021 to FY2026).
- By fiscal year, Return on Assets [ROA] came in at -47.51% in FY2025 (-9.53 pp), -37.98% in FY2024 (-6.56 pp), -31.41% in FY2023 (-7.91 pp) and -23.51% in FY2022 (-2.96 pp).
- Five-year quarterly Return on Assets [ROA] spans a low of -100.90% in fiscal Q1 2027 and a high of -21.88% in fiscal Q3 2022.
- Year over year, Return on Assets [ROA] has now declined in each of the last 20 quarters, with an average year-over-year change of -25.40 percentage points over the last eight quarters.
- Over the past five years, the year-over-year drop in Return on Assets [ROA] ranged from 0.18 percentage points (fiscal Q1 2024) to 51.28 percentage points (fiscal Q4 2026).
- Per Business Quant data, the three fiscal quarters before Q2 2027 came in at -100.90% (Q1 2027), -94.11% (Q4 2026) and -86.95% (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 11.03% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 7.57% |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 2.00% |
| 10 | Replimune | 2.40 Bn | 1.35 Bn | - | -86.17% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -86.17% |
| Jun 30, 2026 | -100.90% |
| Mar 31, 2026 | -94.11% |
| Dec 31, 2025 | -86.95% |
| Sep 30, 2025 | -72.13% |
| Jun 30, 2025 | -55.00% |
| Mar 31, 2025 | -42.83% |
| Dec 31, 2024 | -41.43% |
| Sep 30, 2024 | -41.24% |
| Jun 30, 2024 | -43.03% |
| Mar 31, 2024 | -42.29% |
| Dec 31, 2023 | -38.34% |
| Sep 30, 2023 | -34.05% |
| Jun 30, 2023 | -29.04% |
| Mar 31, 2023 | -26.31% |
| Dec 31, 2022 | -28.15% |
| Sep 30, 2022 | -32.79% |
| Jun 30, 2022 | -28.87% |
| Mar 31, 2022 | -24.92% |
| Dec 31, 2021 | -21.88% |
API Access
Replimune Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=REPL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "REPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=REPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();